Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
730
Trial Sponsor
Clinical Trial Start Date
April 1, 2019
0Primary Completion Date
2020
0Study Completion Date
2020
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
PTX-0220
Placebo0
Interventional Trial Phase
Phase 30
Phase 20
Participating Facility
Official Name
A Multicenter, Four-Part, Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Adults With Moderate to Severe Pachyonychia Congenita0
Last Updated
August 19, 2020
0Allocation Type
Randomized0
Intervention Model
Sequential Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0
Study summary
This study evaluates the safety and efficacy of PTX-022, topical rapamycin, in the treatment of adults with moderate to severe Pachyonychia Congenita. This study includes four-parts, and if a participant completes all parts, the participant will have received at least 3-months of PTX-022 treatment.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
